Funding Received
$28.3 Million in 2 Rounds from 5 Investors
Most Recent Funding
$18.9 Million Series D on October 16, 2013
Founded:
2005
Headquarters:
Paris
Description:
THERAVECTYS develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.
Categories:
Biotechnology
Website:
http://www.theravectys.com

Detailed Description

Update

THERAVECTYS is a development-stage biotechnology company with a novel vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other diseases and conditions. Their first clinical studies will be in HIV/AIDS, using their lead product, a therapeutic vaccine, which has shown promising efficacy and safety in non-human primates.

Current Team (2)

Update

Funding Rounds (2) - $28.3M

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    B√Ętiment Pasteur Biotop

    28 rue du Docteur Roux

    Paris, 75015

    FRA

Images (1)

Update
  • 2881c8bb20495a80f07e6fc097349aae